LORETTTA M ITRI
CIK 1137918 · CHIEF MEDICAL OFFICER · last filed 2024-03-04
LORETTTA M ITRI is a CHIEF MEDICAL OFFICER who has filed 40 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AADI, was dated Mar 4, 2024. Across all open-market trades the lifetime net is +$64.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $691.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$691.3K
3
40
$64.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. (AADI) Delisted | CHIEF MEDICAL OFFICER | — | $2.05 | — | $0 | 4 | 2024-03-04 |
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Medical Officer | 0 | — | — | $0 | 2 | 2020-10-23 |
| GNTA | Pres. & CMO | 369,695 | $1.87 | $691.3K | $64.0K | 2 | 2007-05-15 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-04 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-25 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-23 | IMMUNOMEDICS INC (IMMU) Delisted | Disp (D) | −15,000 | $0 | EDGAR |
| 2020-02-18 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-15 | — | Grant (A) | +650,000,000 | $0 | |
| 2011-09-23 | — | — | — | $0 | |
| 2011-03-25 | — | — | — | $0 | |
| 2011-03-21 | — | — | — | $0 |